Prothena Corporation plc

$17.70 1.20%
NASDAQ: PRTA
Market Cap.: 951.9 M S
P/E: -18.83 x3.3
EPS: -0.94 x 5.9
Earnings Call
3 days, 5 hours from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 469,367
251,624 Moderate Low
Performance Ranks (Intraday)
Ireland:

8th

out of

48

Healthcare:

195th

out of

792

Biotechnology:

82nd

out of

227

Peer Group:

2nd

out of

4

About

Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is …